Postbiotics and their potential applications in early life nutrition and beyond

International Journal of Molecular Sciences

Volumn 20, Issue 19, 2019, Pages

  Wegh, Carrie A M ^a   Geerlings, Sharon Y ^a   Knol, Jan ^a,b   Roeselers, Guus ^b   Belzer, Clara ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

Fermented infant formula; Gut microbiota; Postbiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ATOPIC DERMATITIS; DIARRHEA; HOST MICROBE INTERACTION; HUMAN; IMMUNONUTRITION; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; NUTRITIONAL STATUS; REVIEW; STREPTOCOCCUS THERMOPHILUS; ADULT; INFANT; MICROBIOLOGY;

ADULT; DERMATITIS, ATOPIC; DIARRHEA; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; NUTRITIONAL STATUS; PROBIOTICS;

EID: 85072567802     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms20194673     Document Type: Review

References (119)

1. Honda, K.; Littman, D.R. The microbiota in adaptive immune homeostasis and disease. Nature 2016, 535, 75.
2. Fischbach, M.A.; Segre, J.A. Signaling in host-associated microbial communities. Cell 2016, 164, 1288-1300.
3. Lozupone, C.A.; Stombaugh, J.I.; Gordon, J.I.; Jansson, J.K.; Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489, 220.
4. Sommer, F.; Anderson, J.M.; Bharti, R.; Raes, J.; Rosenstiel, P. The resilience of the intestinal microbiota influences health and disease. Nat. Rev. Microbiol. 2017, 15, 630.
5. Skelly, A.N.; Sato, Y.; Kearney, S.; Honda, K. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat. Rev. Immunol. 2019.
6. Zmora, N.; Suez, J.; Elinav, E. You are what you eat: Diet, health and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 35-56.
7. Dictionary.com. Biotic. Available online: https://www.dictionary.com/browse/biotical (accessed on 5 February 2019).
8. FAO/WHO. Food and Agriculture Organization of the United Nations/World Health Organization Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Available online: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf (accessed on 5 February 2019).
9. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO). Guidelines for the Evaluation of Probiotics in Food. In Joint Fao/Who Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; WHO: London, ON, Canada, 2002.
10. O’Toole, P.W.; Marchesi, J.R.; Hill, C. Next-generation probiotics: The spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2017, 2, 17057.
11. Collado, M.C.; Isolauri, E.; Salminen, S.; Sanz, Y. The impact of probiotic on gut health. Curr. Drug Metab. 2009, 10, 68-78.
12. Bermudez-Brito, M.; Plaza-Diaz, J.; Munoz-Quezada, S.; Gomez-Llorente, C.; Gil, A. Probiotic mechanisms of action. Ann. Nutr. Metab. 2012, 61, 160-174.
13. Vyas, U.; Ranganathan, N. Probiotics, prebiotics, and synbiotics: Gut and beyond. Gastroenterol. Res. Pract. 2012, 2012, 872716.
14. Sánchez, B.; Delgado, S.; Blanco-Míguez, A.; Lourenço, A.; Gueimonde, M.; Margolles, A. Probiotics, gut microbiota, and their influence on host health and disease. Mol. Nutr. Food Res. 2017, 61, 1600240.
15. Hemarajata, P.; Versalovic, J. Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Ther. Adv. Gastroenterol. 2013, 6, 39-51.
16. Sanders, M.E.; Merenstein, D.J.; Reid, G.; Gibson, G.R.; Rastall, R.A. Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nat. Rev. Gastroentero. Hepatol. 2019.
17. Hotel, A.C.P.; Cordoba, A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prevention 2001, 5, 1-10.
18. Thomas, D.W.; Greer, F.R. Probiotics and prebiotics in pediatrics. Pediatrics 2010, 126, 1217-1231.
19. Suez, J.; Zmora, N.; Segal, E.; Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 2019, 25, 716-729.
20. Thomas, C.M.; Versalovic, J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010, 1, 148-163.
21. Kim, S.K.; Guevarra, R.B.; Kim, Y.T.; Kwon, J.; Kim, H.; Cho, J.H.; Kim, H.B.; Lee, J.H. Role of probiotics in human gut microbiome-associated diseases. J. Microbiol. Biotechnol. 2019.
22. Gibson, G.R.; Hutkins, R.; Sanders, M.E.; Prescott, S.L.; Reimer, R.A.; Salminen, S.J.; Scott, K.; Stanton, C.; Swanson, K.S.; Cani, P.D.; et al. Expert consensus document: The international scientific association for probiotics and prebiotics (isapp) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Amp Hepatol. 2017, 14, 491.
23. Giovannini, M.; Verduci, E.; Gregori, D.; Ballali, S.; Soldi, S.; Ghisleni, D.; Riva, E.; Group, P.T.S. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: Randomized multicenter trial. J. Am. Coll. Nutr. 2014, 33, 385-393.
24. Vandenplas, Y.; Zakharova, I.; Dmitrieva, Y. Oligosaccharides in infant formula: More evidence to validate the role of prebiotics. Br. J. Nutr. 2015, 113, 1339-1344.
25. Sierra, C.; Bernal, M.-J.; Blasco, J.; Martínez, R.; Dalmau, J.; Ortuno, I.; Espín, B.; Vasallo, M.-I.; Gil, D.; Vidal, M.-L. Prebiotic effect during the first year of life in healthy infants fed formula containing gos as the only prebiotic: A multicentre, randomised, double-blind and placebo-controlled trial. Eur. J. Nutr. 2015, 54, 89-99.
26. Wegh, C.A.; Schoterman, M.H.; Vaughan, E.E.; Belzer, C.; Benninga, M.A. The effect of fiber and prebiotics on children’s gastrointestinal disorders and microbiome. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 1031-1045.
27. Bertelsen, R.J.; Jensen, E.T.; Ringel-Kulka, T. Use of probiotics and prebiotics in infant feeding. Best Pract. Res. Clin. Gastroenterol. 2016, 30, 39-48.
28. Macfarlane, S.; Macfarlane, G.; Cummings, J.T. Prebiotics in the gastrointestinal tract. Aliment. Pharmacol. Ther. 2006, 24, 701-714.
29. Roberfroid, M.; Gibson, G.R.; Hoyles, L.; McCartney, A.L.; Rastall, R.; Rowland, I.; Wolvers, D.; Watzl, B.; Szajewska, H.; Stahl, B. Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 2010, 104, S1-S63.
30. Gurry, T. Synbiotic approaches to human health and well-being. Microb. Biotechnol. 2017, 10, 1070-1073.
31. Burks, A.W.; Harthoorn, L.F.; Van Ampting, M.T.; Oude Nijhuis, M.M.; Langford, J.E.; Wopereis, H.; Goldberg, S.B.; Ong, P.Y.; Essink, B.J.; Scott, R.B. Synbiotics-supplemented amino acid-based formula supports adequate growth in cow’s milk allergic infants. Pediatr. Allergy Immunol. 2015, 26, 316-322.
32. Van der Aa, L.; Heymans, H.; Van Aalderen, W.; Sillevis Smitt, J.; Knol, J.; Ben Amor, K.; Goossens, D.; Sprikkelman, A.; Group, S.S. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin. Exp. Allergy 2010, 40, 795-804.
33. Van der Aa, L.; Van Aalderen, W.; Heymans, H.; Henk Sillevis Smitt, J.; Nauta, A.; Knippels, L.; Ben Amor, K.; Sprikkelman, A.; Group, S.S. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011, 66, 170-177.
34. Chua, M.C.; Ben-Amor, K.; Lay, C.; Goh, A.E.; Chiang, W.C.; Rao, R.; Chew, C.; Chaithongwongwatthana, S.; Khemapech, N.; Knol, J. Effect of synbiotic on the gut microbiota of cesarean delivered infants: A randomized, double-blind, multicenter study. J. Pediatr. Gastroenterol. Nutr. 2017, 65, 102-106.
35. Nikbakht, E.; Khalesi, S.; Singh, I.; Williams, L.T.; West, N.P.; Colson, N. Effect of probiotics and synbiotics on blood glucose: A systematic review and meta-analysis of controlled trials. Eur. J. Nutr. 2018, 57, 95-106.
36. Miller, L.E.; Ouwehand, A.C.; Ibarra, A. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: Systematic review and meta-analysis of randomized controlled trials. Ann. Gastroenterol. 2017, 30, 629.
37. Arumugam, S.; Lau, C.S.; Chamberlain, R.S. Probiotics and synbiotics decrease postoperative sepsis in elective gastrointestinal surgical patients: A meta-analysis. J. Gastrointest. Surg. 2016, 20, 1123-1131.
38. Umu, O.C.O.; Rudi, K.; Diep, D.B. Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb. Ecol. Health. Dis. 2017, 28, 1348886.
39. O’Grady, J.; O’Connor, E.M.; Shanahan, F. Review article: Dietary fibre in the era of microbiome science. Aliment. Pharmacol. Ther. 2019, 49, 506-515.
40. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417-1435.
41. Markowiak, P.; Śliżewska, K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 2017, 9, 1021.
42. Konstantinov, S.R.; Kuipers, E.J.; Peppelenbosch, M.P. Functional genomic analyses of the gut microbiota for crc screening. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 741.
43. Taverniti, V.; Guglielmetti, S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: Proposal of paraprobiotic concept). Genes Nutr. 2011, 6, 261.
44. Aguilar-Toalá, J.; Garcia-Varela, R.; Garcia, H.; Mata-Haro, V.; González-Córdova, A.; Vallejo-Cordoba, B.; Hernández-Mendoza, A. Postbiotics: An evolving term within the functional foods field. Trends Food Sci. Technol. 2018, 75, 105-114.
45. Agostoni, C.; Goulet, O.; Kolacek, S.; Koletzko, B.; Moreno, L.; Puntis, J.; Rigo, J.; Shamir, R.; Szajewska, H.; Turck, D. Fermented infant formulae without live bacteria. J. Pediatric Gastroenterol. Nutr. 2007, 44, 392-397.
46. Szajewska, H.; Skórka, A.; Pieścik-Lech, M. Fermented infant formulas without live bacteria: A systematic review. Eur. J. Pediatr. 2015, 174, 1413-1420.
47. Ouwehand, A.; Tölkkö, S.; Kulmala, J.; Salminen, S.; Salminen, E. Adhesion of inactivated probiotic strains to intestinal mucus. Lett. Appl. Microbiol. 2000, 31, 82-86.
48. Kataria, J.; Li, N.; Wynn, J.L.; Neu, J. Probiotic microbes: Do they need to be alive to be beneficial? Nutr. Rev. 2009, 67, 546-550.
49. Deshpande, G.; Athalye-Jape, G.; Patole, S. Para-probiotics for preterm neonates-the next frontier. Nutrients 2018, 10, 871.
50. Olle, B. Medicines from microbiota. Nat. Biotechnol. 2013, 31, 309.
51. Lahtinen, S.J. Probiotic viability-does it matter? Microb. Ecol. Health Dis. 2012, 23, 18567.
52. de Almada, C.N.; Almada, C.N.; Martinez, R.C.R.; Sant’Ana, A.S. Paraprobiotics: Evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci. Technol. 2016, 58, 96-114.
53. Gosálbez, L.; Ramón, D. Probiotics in transition: Novel strategies. Trends Biotechnol. 2015, 33, 195-196.
54. Wang, Y.; Xie, J.; Wang, N.; Li, Y.; Sun, X.; Zhang, Y.; Zhang, H. Lactobacillus casei zhang modulate cytokine and toll-like receptor expression and beneficially regulate poly i: C-induced immune responses in raw264. 7 macrophages. Microbiol. Immunol. 2013, 57, 54-62.
55. Kamiya, T.; Wang, L.; Forsythe, P.; Goettsche, G.; Mao, Y.; Wang, Y.; Tougas, G.; Bienenstock, J. Inhibitory effects of lactobacillus reuteri on visceral pain induced by colorectal distension in sprague-dawley rats. Gut 2006, 55, 191-196.
56. Imaoka, A.; Shima, T.; Kato, K.; Mizuno, S.; Uehara, T.; Matsumoto, S.; Setoyama, H.; Hara, T.; Umesaki, Y. Anti-inflammatory activity of probiotic bifidobacterium: Enhancement of il-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of il-8 secretion in ht-29 cells. World J. Gastroenterol. 2008, 14, 2511-2516.
57. Hoarau, C.; Lagaraine, C.; Martin, L.; Velge-Roussel, F.; Lebranchu, Y. Supernatant of bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 2006, 117, 696-702.
58. Menard, S.; Laharie, D.; Asensio, C.; Vidal-Martinez, T.; Candalh, C.; Rullier, A.; Zerbib, F.; Megraud, F.; Matysiak-Budnik, T.; Heyman, M. Bifidobacterium breve and streptococcus thermophilus secretion products enhance t helper 1 immune response and intestinal barrier in mice. Exp. Biol. Med. 2005, 230, 749-756.
59. Zagato, E.; Mileti, E.; Massimiliano, L.; Fasano, F.; Budelli, A.; Penna, G.; Rescigno, M. Lactobacillus paracasei cba l74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo. PLoS ONE 2014, 9, e87615.
60. Korcz, E.; Kerenyi, Z.; Varga, L. Dietary fibers, prebiotics, and exopolysaccharides produced by lactic acid bacteria: Potential health benefits with special regard to cholesterol-lowering effects. Food Funct. 2018, 9, 3057-3068.
61. Ahmadi Badi, S.; Moshiri, A.; Fateh, A.; Rahimi Jamnani, F.; Sarshar, M.; Vaziri, F.; Siadat, S.D. Microbiota-derived extracellular vesicles as new systemic regulators. Front. Microbiol. 2017, 8, 1610.
62. Ryan, P.M.; Ross, R.P.; Fitzgerald, G.F.; Caplice, N.M.; Stanton, C. Sugar-coated: Exopolysaccharide producing lactic acid bacteria for food and human health applications. Food Funct. 2015, 6, 679-693.
63. Salazar, N.; Gueimonde, M.; de Los Reyes-Gavilan, C.G.; Ruas-Madiedo, P. Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermentable substrates by the intestinal microbiota. Crit. Rev. Food Sci. Nutr. 2016, 56, 1440-1453.
64. Zeidan, A.A.; Poulsen, V.K.; Janzen, T.; Buldo, P.; Derkx, P.M.F.; Oregaard, G.; Neves, A.R. Polysaccharide production by lactic acid bacteria: From genes to industrial applications. FEMS Microbiol. Rev. 2017, 41, 168-200.
65. Das, D.; Baruah, R.; Goyal, A.Afood additive with prebiotic properties of an alpha-d-glucan fromlactobacillus plantarum dm5. Int. J. Biol. Macromol. 2014, 69, 20-26.
66. Hongpattarakere, T.; Cherntong, N.; Wichienchot, S.; Kolida, S.; Rastall, R.A. In vitro prebiotic evaluation of exopolysaccharides produced by marine isolated lactic acid bacteria. Carbohyd. Polym. 2012, 87, 846-852.
67. Wang, K.; Li, W.; Rui, X.; Chen, X.; Jiang, M.; Dong, M. Characterization of a novel exopolysaccharide with antitumor activity from lactobacillus plantarum 70810. Int. J. Biol. Macromol. 2014, 63, 133-139.
68. Ellis, T.N.; Kuehn, M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. MMBR 2010, 74, 81-94.
69. Chelakkot, C.; Choi, Y.; Kim, D.-K.; Park, H.T.; Ghim, J.; Kwon, Y.; Jeon, J.; Kim, M.-S.; Jee, Y.-K.; Gho, Y.S. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp. Mol. Med. 2018, 50, e450.
70. Fábrega, M.J.; Aguilera, L.; Giménez, R.; Varela, E.; Alexandra Cañas, M.; Antolín, M.; Badía, J.; Baldomà, L. Activation of immune and defense responses in the intestinal mucosa by outer membrane vesicles of commensal and probiotic escherichia coli strains. Front. Microbiol. 2016, 7, 705.
71. Kang, C.-s.; Ban, M.; Choi, E.-J.; Moon, H.-G.; Jeon, J.-S.; Kim, D.-K.; Park, S.-K.; Jeon, S.G.; Roh, T.-Y.; Myung, S.-J. Extracellular vesicles derived from gut microbiota, especially akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 2013, 8, e76520.
72. Van de Heijning, B.; Berton, A.; Bouritius, H.; Goulet, O. GI symptoms in infants are a potential target for fermented infant milk formulae: A review. Nutrients 2014, 6, 3942-3967.
73. Vandenplas, Y.; Ludwig, T.; Bouritius, H.; Alliet, P.; Forde, D.; Peeters, S.; Huet, F.; Hourihane, J. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic. Acta Paediatrica 2017, 106, 1150-1158.
74. Huet, F.; Abrahamse-Berkeveld, M.; Tims, S.; Simeoni, U.; Beley, G.; Savagner, C.; Vandenplas, Y.; Hourihane, J.O.B. Partly fermented infant formulae with specific oligosaccharides support adequate infant growth and are well-tolerated. J. Pediatric Gastroenterol. Nutr. 2016, 63, e43.
75. Herrera, A.R.; Ludwig, T.; Bouritius, H.; Rubio, R.P.; Munoz, A.; Agosti, M.; Lista, G.; Corvaglia, L.T.; Navero, J.L. Op-18 the combination of scgos/lcfos and fermented infant formula softens stools of infants compared to unfermented infant formula without scgos/lcfos. J. Pediatr. Gastroenterol. Nutr. 2015, 61, 516-517.
76. Campeotto, F.; Suau, A.; Kapel, N.; Magne, F.; Viallon, V.; Ferraris, L.; Waligora-Dupriet, A.-J.; Soulaines, P.; Leroux, B.; Kalach, N. A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory iga. Br. J. Nutr. 2011, 105, 1843-1851.
77. Morisset, M.; Aubert-Jacquin, C.; Soulaines, P.; Moneret-Vautrin, D.; Dupont, C. Anon-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur. J. Clin. Nutr. 2011, 65, 175.
78. Indrio, F.; Ladisa, G.; Mautone, A.; Montagna, O. Effect of a fermented formula on thymus size and stool ph in healthy term infants. Pediatr. Res. 2007, 62, 98.
79. Mullié, C.; Yazourh, A.; Thibault, H.; Odou, M.-F.; Singer, E.; Kalach, N.; Kremp, O.; Romond, M.-B. Increased poliovirus-specific intestinal antibody response coincides with promotion of bifidobacterium longum-infantis and bifidobacterium breve in infants: A randomized, double-blind, placebo-controlled trial. Pediatric Res. 2004, 56, 791.
80. Thibault, H.; Aubert-Jacquin, C.; Goulet, O. Effects of long-term consumption of a fermented infant formula (with bifidobacterium breve c50 and streptococcus thermophilus 065) on acute diarrhea in healthy infants. J. Pediatric Gastroenterol. Nutr. 2004, 39, 147-152.
81. Campeotto, F.; Butel, M.; Kalach, N.; Derrieux, S.; Aubert-Jacquin, C.; Barbot, L.; Francoual, C.; Dupont, C.; Kapel, N. High faecal calprotectin concentrations in newborn infants. Arch. Dis. Child. -Fetal Neonatal Ed. 2004, 89, 353-355.
82. Boudraa, G.; Boukhrelda, M.; de Lempdes, J.R.; Blareau, J.; Touhami, M. 41 effect of fermented infant formula on incidence of diarrhea at early weaning. J. Pediatric Gastroenterol. Nutr. 1994, 19, 339.
83. Thapar, N.; Sanderson, I.R. Diarrhoea in children: An interface between developing and developed countries. Lancet 2004, 363, 641-653.
84. Guarino, A.; Ashkenazi, S.; Gendrel, D.; Vecchio, A.L.; Shamir, R.; Szajewska, H. European society for pediatric gastroenterology, hepatology, and nutrition/european society for pediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in europe: Update 2014. J. Pediatric Gastroenterol. Nutr. 2014, 59, 132-152.
85. Lievin-Le Moal, V.; Sarrazin-Davila, L.E.; Servin, A.L. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of lactobacillus acidophilus strain lb against nonrotavirus diarrhea. Pediatrics 2007, 120, 795-803.
86. Kaila, M.; Isolauri, E.; Saxelin, M.; Arvilommi, H.; Vesikari, T. Viable versus inactivated lactobacillus strain gg in acute rotavirus diarrhoea. Arch. Dis. Child. 1995, 72, 51-53.
87. Sharieff, W.; Bhutta, Z.; Schauer, C.; Tomlinson, G.; Zlotkin, S. Micronutrients (including zinc) reduce diarrhoea in children: The pakistan sprinkles diarrhoea study. Arch. Dis. Child. 2006, 91, 573-579.
88. Kirjavainen, P.V.; Salminen, S.J.; Isolauri, E. Probiotic bacteria in the management of atopic disease:Underscoring the importance of viability. J. Pediatric Gastroenterol. Nutr. 2003, 36, 223-227.
89. Corsello, G.; Carta, M.; Marinello, R.; Picca, M.; De Marco, G.; Micillo, M.; Ferrara, D.; Vigneri, P.; Cecere, G.; Ferri, P. Preventive effect of cow’s milk fermented with lactobacillus paracasei cba l74 on common infectious diseases in children: A multicenter randomized controlled trial. Nutrients 2017, 9, 669.
90. Berni Canani, R.; De Filippis, F.; Nocerino, R.; Laiola, M.; Paparo, L.; Calignano, A.; De Caro, C.; Coretti, L.; Chiariotti, L.; Gilbert, J.A.; et al. Specific signatures of the gut microbiota and increased levels of butyrate in children treated with fermented cow’s milk containing heat-killed lactobacillus paracasei cba l74. Appl. Environ. Microbiol. 2017, 83, e01206-17.
91. Peng, G.C.; Hsu, C.H. The efficacy and safety of heat-killed lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatric Allergy Immunol. 2005, 16, 433-438.
92. Rampengan, N.H.; Manoppo, J.; Warouw, S.M. Comparison of efficacies between live and killed probiotics in children with lactose malabsorption. Southeast Asian J. Trop. Med. Public Health 2010, 41, 474-481.
93. Sawada, D.; Sugawara, T.; Ishida, Y.; Aihara, K.; Aoki, Y.; Takehara, I.; Takano, K.; Fujiwara, S. Effect of continuous ingestion of a beverage prepared with lactobacillus gasseri cp2305 inactivated by heat treatment on the regulation of intestinal function. Food Res. Int. 2016, 79, 33-39.
94. Tarrerias, A.; Costil, V.; Vicari, F.; Letard, J.; Adenis-Lamarre, P.; Aisene, A.; Batistelli, D.; Bonnaud, G.; Carpentier, S.; Dalbies, P. The effect of inactivated lactobacillus lb fermented culture medium on symptom severity: Observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig. Dis. 2011, 29, 588-591.
95. Xiao, S.D.; Zhang, D.Z.; Lu, H.; JIANG, S.H.; LIU, H.Y.; Wang, G.S.; XU, G.M.; Zhang, Z.B.; LIN, G.J.; WANG, G.L. Multicenter randomized controlled trial of heat-killed lactobacillus acidophilus lb in patients with chronic diarrhea. Chin. J. Dig. Dis. 2002, 3, 167-171.
96. Moroi, M.; Uchi, S.; Nakamura, K.; Sato, S.; Shimizu, N.; Fujii, M.; Kumagai, T.; Saito, M.; Uchiyama, K.; Watanabe, T. Beneficial effect of a diet containing heat-killed lactobacillus paracasei k71 on adult type atopic dermatitis. J. Dermatol. 2011, 38, 131-139.
97. Shinkai, S.; Toba, M.; Saito, T.; Sato, I.; Tsubouchi, M.; Taira, K.; Kakumoto, K.; Inamatsu, T.; Yoshida, H.; Fujiwara, Y. Immunoprotective effects of oral intake of heat-killed lactobacillus pentosus strain b240 in elderly adults: A randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 2013, 109, 1856-1865.
98. Arimori, Y.; Nakamura, R.; Hirose, Y.; Murosaki, S.; Yamamoto, Y.; Shidara, O.; Ichikawa, H.; Yoshikai, Y. Daily intake of heat-killed lactobacillus plantarum l-137 enhances type i interferon production in healthy humans and pigs. Immunopharmacol. Immunotoxicol. 2012, 34, 937-943.
99. Tapiovaara, L.; Kumpu, M.; Mäkivuokko, H.; Waris, M.; Korpela, R.; Pitkäranta, A.; Winther, B. Human rhinovirus in experimental infection after peroral lactobacillus rhamnosus gg consumption, a pilot study. In International Forum of Allergy & Rhinology; Wiley Online Library: Hoboken, NJ, USA, 2016; pp. 848-853.
100. Scheppach, W. Effects of short chain fatty acids on gut morphology and function. Gut 1994, 35, 35-38.
101. Koh, A.; DeVadder, F.; Kovatcheva-Datchary, P.; Bäckhed, F. Fromdietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 2016, 165, 1332-1345.
102. den Besten, G.; Lange, K.; Havinga, R.; van Dijk, T.H.; Gerding, A.; van Eunen, K.; Müller, M.; Groen, A.K.; Hooiveld, G.J.; Bakker, B.M. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, 900-910.
103. Bedford, A.; Gong, J. Implications of butyrate and its derivatives for gut health and animal production. Anim. Nutr. 2018, 4, 151-159.
104. Wu, X.; Wu, Y.; He, L.; Wu, L.; Wang, X.; Liu, Z. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J. Cancer 2018, 9, 2510-2517.
105. Liu, H.; Wang, J.; He, T.; Becker, S.; Zhang, G.; Li, D.; Ma, X. Butyrate: A double-edged sword for health? Adv. Nutr. 2018, 9, 21-29.
106. Johnstone, R.W. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 2002, 1, 287.
107. Singh, N.; Thangaraju, M.; Prasad, P.D.; Martin, P.M.; Lambert, N.A.; Boettger, T.; Offermanns, S.; Ganapathy, V. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 2010, 285, 27601-27608.
108. Lukovac, S.; Belzer, C.; Pellis, L.; Keijser, B.J.; deVos, W.M.; Montijn, R.C.; Roeselers, G. Differential modulation by akkermansia muciniphila and faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 2014, 5, e01438.
109. Gill, P.; van Zelm, M.; Muir, J.; Gibson, P. Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment. Pharmacol. Ther. 2018, 48, 15-34.
110. Morrison, D.J.; Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7, 189-200.
111. Louis, P.; Hold, G.L.; Flint, H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12, 661.
112. Scott, K.P.; Martin, J.C.; Campbell, G.; Mayer, C.-D.; Flint, H.J. Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the human gut bacterium " Roseburia inulinivorans”. J. Bacteriol. 2006, 188, 4340-4349.
113. Riviere, A.; Selak, M.; Lantin, D.; Leroy, F.; De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria:Importance and strategies for their stimulation in the human gut. Front. Microbiol. 2016, 7, 979.
114. Rodionov, D.A.; Arzamasov, A.A.; Khoroshkin, M.S.; Iablokov, S.N.; Leyn, S.A.; Peterson, S.N.; Novichkov, P.S.; Osterman, A.L. Micronutrient requirements and sharing capabilities of the human gut microbiome. Front. Microbiol. 2019, 10, 1316.
115. Sharma, V.; Rodionov, D.A.; Leyn, S.A.; Tran, D.; Iablokov, S.N.; Ding, H.; Peterson, D.A.; Osterman, A.L.; Peterson, S.N. B vitamin sharing promotes stability of gut microbial communities. Front. Microbiol. 2019, 10, 1485.
116. Castro-Bravo, N.; Wells, J.M.; Margolles, A.; Ruas-Madiedo, P. Interactions of surface exopolysaccharides from bifidobacterium and lactobacillus within the intestinal environment. Front. Microbiol. 2018, 9, 2426.
117. Salazar, N.; Gueimonde, M.; Hernandez-Barranco, A.M.; Ruas-Madiedo, P.; de los Reyes-Gavilan, C.G. Exopolysaccharides produced by intestinal bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl. Environ. Microbiol. 2008, 74, 4737-4745.
118. Kareem, K.Y.; Hooi Ling, F.; Teck Chwen, L.; May Foong, O.; Anjas Asmara, S. Inhibitory activity of postbiotic produced by strains of lactobacillus plantarum using reconstituted media supplemented with inulin. Gut Pathog. 2014, 6, 23.
119. Dobson, A.; Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocin production: A probiotic trait? Appl. Environ. Microbiol. 2012, 78, 1-6.